Biotech funding challenges: VC, IPOs, and the importance of industry partnerships

Explore key biotech funding challenges in 2025. Learn how VCs, IPO trends, and industry partnerships shape success in a shifting biotech financing landscape.

New Podcast Landing Page

Pulse Check: The Cardiovascular Conversations

David Simpson, MSc

David (Dave) Simpson serves as Senior Vice President and Managing Director for Fortrea’s. Clinical Pharmacology Services (CPS). CPS oversees Phase I clinical trials which involves the study of investigational drugs in healthy volunteers.

Mark Lovern, Ph. D.

Dr Mark Lovern is Executive Director of Medical Science Services at Fortrea, and has 25+ years of experience in the application of model-informed drug development (MIDD).

Angela Hassman

Angela Hassman is a seasoned clinical research leader with over 2 decades of experience in early-phase clinical trial operations.

Dr Jim Bush

Dr. Jim Bush, Vice President Medical Services, Clinical Pharmacology and Principal Investigator. Dr.

A patient-centric approach to advance respiratory drug development

Targeting the heart of the problem: why coronary inflammation is cardiovascular medicine's next frontier